Lipocine Inc. (LPCN) › Operating IncomeLipocine Inc. (LPCN) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2012: $3.88M2013: -$10.68M2014: -$20.48M2015: -$18.38M2016: -$19.19M2017: -$21.22M2018: -$11.33M2019: -$12.90M2020: -$18.00M2021: $3.15M2022: -$12.12M2023: -$17.93M2024: -$1.16M2025: -$10.37M-$10.37M2012Operating Income (USD)2025Fiscal YearOperating IncomeChange YoY2025-$10.37M-797.9%2024-$1.16M+93.6%2023-$17.93M-48.0%2022-$12.12M-485.3%2021$3.15M+117.5%2020-$18.00M-39.5%2019-$12.90M-13.9%2018-$11.33M+46.6%2017-$21.22M-10.6%2016-$19.19M-4.4%2015-$18.38M+10.2%2014-$20.48M-91.7%2013-$10.68M-375.5%2012$3.88M—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share